The AH trade that I had referenced was available on the time/tape on Fidelity. The activity had occured at about 15 minutes after the close on Monday. Certainly did not translate into positive activity today though. I did think, overall, that today's pullback on some lighter volume was generally constructive. Hope we stabilize in this level and then proceed upward after a time.
Interesting AH trade today about 15 minutes after close. A block of 29k+ shares traded up to 8.16/share.
Should continue to show interest in the morning IMO.
Just announced that an outfit, Broadfin Capital, just filed that they have almost an 8% holding. Gaining institutional following and momentum very quickly.
No one ever got broke by taking profit. BUT, with this starting to gain momentum with its CELG backing in a big way, potential for uplifting, small market cap and float---this may just be the beginning of a long run up in a way that I could not have previously believed. Just one product such as a patch for post herpetic neuralgia (pain of shingles) and this thing could be worth 1-2 billion dollars (100-200 dollars/share). I think that this had been Frost's reason for investing in this company years ago. With Celgene, this could become a reality.
Current level of arount 7.50 is actually only the level that ALQA gave to Frost to get him to invest a long time ago (17 cents/sharex43.75). That was considered a bargain price back then....so I suppose that the recent developments probably suggest that there is a LONG way to go on the upside with Celgene involved and that this may well be only the beginning of a long way up. BTW--got back in a few days ago and plan to hold now!
gme-I was not at all suggesting that ALQA cannot become the next AMGN. I knew a young biochemist who had to be talked into taking shares of Amgen at fractions of a penny/share back in the 70's instead of a few thousand dollars in salary to work at the startup of Amgen before it was even a public company. Needless to say, he has become a 250+ million dollar man....clearly such things can and will happen. In addition, I am not suggesting an individual run out and by the "blue chips" at record valuations. I merely suggested that tiny biotechs or other specs can come and go (more likely go away) and are probably not the basis of developing significant wealth in most cases. I just tried to make a helpful suggestion to someone who apparently has suffered significant financial loss (losing his "home and everything"). Admitedly, my recent timing in ALQA has been bad...made a few dollars but left 30K on the table in a matter of a couple of days-no question about that decision. Fortunately, whether I have those dollars or not will not make any difference to my financial wellbeing. Best regards.
Hi Selftaught-I read your note and felt seriously badly for your plight of having suffered the pains of losing your home "and everything" the obvious trauma of the recession. I am very happy that you sound like you are "on the mend" and are feeling positive about ALQA(D). I do hope that it continues for you. The thrust of my observation, and it is probably not my business but your note made a sincere impression upon me, is that I believe if you suffered so badly from the last recession that if you want to own equities that you might concentrate on less speculative plays. Recognize that today's price of ALQA(D) only really represents a price of about 12.5 cents per share prior to the reverse split. Of course, I do not know your current financial situation--perhaps you have inherited a large sum of money or won the lottery....my advise, and I mean this from the bottom of my being, is that you might consider building a "blue chip portfolio" before speculating in a pink sheet security. This is said by me with complete sincerity....I have done very well financially and can withstand downturns without much to worry about...I merely wish you success and peace of mind in your endeavor. Please do not take my comments as anything but interest in your well being believe or not. Best regards.
bil-congratulations to all those who had held on to their long positions. I know that you had an incredible day today. Well, I certainly left alot of money on the table today....I figure somewhat in the neighborhood of 35K today alone! I don't fully understand the logic of the events that have been overwhelming in this equity in the last couple of days, but that is what makes "horse racing". Good luck to all!
Bil-I admire your enthusiasm for ALQA. Phil Frost could have written a check for the entire company from his checking account if he had thought that it was worthwhile. The fact that he is/has liquidated his position speaks to why I also got rid of my 500,000 shares-made a few dollars and left. There is, at this point in time, nothing going on with this company. Absolutely nothing. New management strikes me as an educated group of folks who speak "the lingo" but there is nothing going on so far. Of course, it is early and you may well be correct that it turns out to be a good investment.
I do think that it is delusional to suggest that any biotech growth funds would have any interest in this company. Best regards.
Correct. The filing was as of 10/30 BUT it was only made public and reported at 3:23 PM EST today, November 18. The equity dropped 11%+ after the announcement of the Frost disposal of shares and the company setting up for a reverse split.
WOW...it is true...a fool and his money are soon parted!
Frost filed a 13G/A regarding his diminished holding at 3:05pm.
ALQA announced the reverse split a few minutes later!
How can you post such an ignorant post? It was released by ALQA investor relations within the last hour!
Don't you folks get the ALQA new releases? There is a BIG time reverse split and Frost has sold over half of his shares.
As much as I would like to believe that a hepatic device might be monetized by ALQA I believe that it is "pie in the sky" thinking to believe that could/would be forthcoming. I do believe that I had read in one of their SEC filings in the recent past that they ceased any kind of development/thinking about such a product.